Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

Find Narasin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

Narasin
Also known as: Narasin a, Compound 79891, Monteban, 55134-13-9, Antibiotic a-28086 factor a, Antibiotic c 7819b
Molecular Formula
C43H72O11
Molecular Weight
765.0  g/mol
InChI Key
VHKXXVVRRDYCIK-CWCPJSEDSA-N
FDA UNII
DZY9VU539P

narasin is a natural product found in Kitasatospora aureofaciens with data available.
1 2D Structure

Narasin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R)-2-[(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid
2.1.2 InChI
InChI=1S/C43H72O11/c1-12-30(35(46)27(8)34(45)28(9)36-23(4)21-24(5)37(51-36)31(13-2)39(47)48)38-25(6)22-26(7)42(52-38)18-15-32(44)43(54-42)20-19-40(11,53-43)33-16-17-41(49,14-3)29(10)50-33/h15,18,23-34,36-38,44-45,49H,12-14,16-17,19-22H2,1-11H3,(H,47,48)/t23-,24-,25-,26+,27-,28-,29-,30-,31+,32+,33+,34+,36+,37+,38-,40-,41+,42-,43-/m0/s1
2.1.3 InChI Key
VHKXXVVRRDYCIK-CWCPJSEDSA-N
2.1.4 Canonical SMILES
CCC(C1C(CC(C(O1)C(C)C(C(C)C(=O)C(CC)C2C(CC(C3(O2)C=CC(C4(O3)CCC(O4)(C)C5CCC(C(O5)C)(CC)O)O)C)C)O)C)C)C(=O)O
2.1.5 Isomeric SMILES
CC[C@H]([C@H]1[C@H](C[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
DZY9VU539P
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4-methylsalinomycin

2. Narasin A

3. Narasin Monosodium Salt

2.3.2 Depositor-Supplied Synonyms

1. Narasin A

2. Compound 79891

3. Monteban

4. 55134-13-9

5. Antibiotic A-28086 Factor A

6. Antibiotic C 7819b

7. Antibiotic A 28086a

8. Salinomycin, 4-methyl-, (4s)-

9. Lilly 79891

10. 4-methylsalinomycin

11. C-7819b

12. Dzy9vu539p

13. Narasine

14. Narasino

15. Narasinum

16. Compd-79891

17. C 7819b

18. Salinomycin, 4-methyl-, (4s)

19. Monteban (tn)

20. Narasine [inn-french]

21. Narasinum [inn-latin]

22. Narasino [inn-spanish]

23. Narasin (usp/inn)

24. (2r)-2-[(2r,3s,5s,6r)-6-[(2s,3s,4s,6r)-6-[(3s,5s,7r,9s,10s,12r,15r)-3-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic Acid

25. Unii-dzy9vu539p

26. Brn 1678311

27. Ai3-29798

28. Narasin [usan:usp:inn:ban]

29. Narasin 100 Microg/ml In Acetonitrile

30. Ncgc00167550-01

31. 2h-pyran-2-acetic Acid, Alpha-ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl-

32. Narasin [usan]

33. Narasin [inn]

34. Narasin [mi]

35. Narasin [mart.]

36. Narasin [usp-rs]

37. Dsstox_cid_26707

38. Dsstox_rid_81840

39. Dsstox_gsid_46707

40. Narasin [green Book]

41. Alpha-ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl-2h-pyran-2-acetic Acid

42. Schembl123401

43. Narasin [usp Impurity]

44. Chembl2104423

45. Dtxsid2046707

46. Gtpl10835

47. Chebi:183815

48. Tox21_112545

49. Zinc85540282

50. Db11432

51. Ncgc00167550-06

52. Ncgc00167550-08

53. Cas-55134-13-9

54. Hy-121410

55. Cs-0081972

56. D05122

57. Q2104314

58. (2r)-2-[(2r,3s,5s,6r)-6-[(2s,3s,4s,6r)-6-[(3s,5s,7r,9s,10s,12r,15r)-3-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.5^{7}.3^{5}]pentadec-13-en-9

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 765.0 g/mol
Molecular Formula C43H72O11
XLogP36.2
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count11
Rotatable Bond Count12
Exact Mass764.50746311 g/mol
Monoisotopic Mass764.50746311 g/mol
Topological Polar Surface Area161 Ų
Heavy Atom Count54
Formal Charge0
Complexity1360
Isotope Atom Count0
Defined Atom Stereocenter Count19
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)


Coccidiostats

Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals. (See all compounds classified as Coccidiostats.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY